Xolair (omalizumab injection), 75 mg/0.5 ml, Rx only, Genentech, Inc., South San Francisco, CA 94080, NDC 50242-214-55
Published August 13, 2025 · Recall initiated: July 30, 2025
Summary
FDA records drug Class II recall D-0572-2025, published August 13, 2025 and initiated July 30, 2025. Recalling firm: Cardinal Health Inc.; Status: Ongoing; Reported quantity: 4 units; Lot: Lot: 3630004, Expires: 10/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Cardinal Health Inc.
- Distributor
- Nationwide Within the U.S.
- Lot
- Lot: 3630004, Expires: 10/31/2025.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAEnoxaparin Sodium Injection, USP, 30 mg/0.3 mL, packaged in 0.3 mL prefilled syringes further packaged in bagsSeptember 3, 2025
- FDAXolair (omalizumab injection), 150 mg/ml, 1 auto-injector, Rx only, Genentech, Inc, South San Francisco, CAAugust 13, 2025
- FDARECOMBINATE, [Antihemophilic Factor (Recombinant)], 5 mL vials, Rx Only, Takeda Pharmaceuticals USA,August 13, 2025
- FDADuloxetine D/R, 30 mg, 30 Caps, RX Only, Packaged as a) 30-count bottle NDC 61919-0482-30, b) 60-count bottle,August 13, 2025
- FDASpironolactone Tablets, USP, 25 mg, 100-count bottle, Rx only, Mfg. by: Frontida BioPharm, Inc., 1100 OrthodoxAugust 13, 2025
- FDAWegovy (semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous UseMay 7, 2025
Questions about this recall
Was Xolair (omalizumab injection), 75 mg/0.5 ml, Rx only, Genentech, Inc., South San Francisco, CA 94080, NDC 50242-214-55 recalled?
Yes. FDA published recall D-0572-2025 on August 13, 2025. Reported hazard: CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.
What should I do if I have this product?
Voluntary: Firm initiated · Letter